









Markets
/
Stocks
/
nasdaq-blrx
/

BioLine RX Ltd

BLRX

View Detailed Chart

4.650USD

+0.050+1.09%

Close 07/17, 16:00（ET）Quotes delayed by 15 min

10.38BMarket Cap

LossP/E TTM



BioLine RX Ltd

4.650

+0.050+1.09%

Overview Company Financials

Financials

Intraday

30m

Today

+1.09%

5 Days

-5.49%

1 Month

-0.43%

6 Months

-4.63%

Year to Date

-45.68%

1 Year

-85.75%

View Detailed Chart

Agency Rating

Analyst Rating

Based on 2 analysts

BUY

Current Rating

26.000

Target Price

465.22%

Upside Space

Strong Buy

Buy

Hold

Sell

Strong Sell

Peer Comparison

554

Total

Median

Average

Company name

Ratings

Analysts

BioLine RX Ltd

BLRX

CRISPR Therapeutics AG

CRSP

Intellia Therapeutics Inc

NTLA

Exact Sciences Corp

EXAS

Ionis Pharmaceuticals Inc

IONS

IQVIA Holdings Inc

IQV

...

111

Indicators



The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

15m

30m

15m

30m

D

Buy

Sell(2)

Neutral(4)

Buy(7)

Indicators

Sell(1)

Neutral(4)

Buy(2)

Indicators

Value

Direction

MACD(12,26,9)

-0.034

Neutral

RSI(14)

52.760

Neutral

STOCH(KDJ)(9,3,3)

57.493

Neutral

ATR(14)

0.326

Low Volatility

CCI(14)

43.951

Neutral

Williams %R

40.782

Buy

TRIX(12,20)

0.131

Sell

StochRSI(14)

70.220

Buy

Moving Average

Sell(1)

Neutral(0)

Buy(5)

Indicators

Value

Direction

MA5

4.634

Buy

MA10

4.610

Buy

MA20

4.519

Buy

MA50

4.272

Buy

MA100

3.691

Buy

MA200

7.581

Sell

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

BioLine RX Ltd is an Israel-based clinical-stage biopharmaceutical company focused on oncology. The Company is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The Company is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.

Ticker SymbolBLRX

CompanyBioLine RX Ltd

CEOMr. Philip Adam (Phil) Serlin

Websitehttps://www.biolinerx.com/